SCHEMBL4607809

SCHEMBL4607809

CS(=O)(=O)NCCc1ccc(-c2ccc(C3CCCC3N)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIA4 P48058 1/20 0.44
KDM1A O60341 8/20 0.42
MAOA P21397 2/20 0.42
MAOB P27338 1/20 0.39
ALDH1A1 P00352 3/20 0.38
ALOX15 P16050 1/20 0.38
POLB P06746 1/20 0.38
LSS P48449 1/20 0.36
CA12 O43570 2/20 0.35
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
CA9 Q16790 2/20 0.35
CA5A P35218 1/20 0.35
CA14 Q9ULX7 1/20 0.35
KCNH2 Q12809 3/20 0.35
HRH3 Q9Y5N1 3/20 0.35
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
TP53 P04637 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4607805 0.83 GRIA4 (0.41) GRIA4KDM1AMAOAALDH1A1ALOX15
SCHEMBL4608720 0.79 GRIA4 (0.60) GRIA4KCNH2
SCHEMBL4607607 0.79 GRIA4 (0.60) GRIA4KCNH2
SCHEMBL5991959 0.78 GRIA4 (0.63) GRIA4ALDH1A1ALOX15POLBLSS
SCHEMBL4608169 0.77 MAOB (0.43) KDM1AMAOBALDH1A1
SCHEMBL4608502 0.73 KDM1A (0.50) KDM1AMAOAMAOBALDH1A1CA12
SCHEMBL10312250 0.72 POLB (0.64) GRIA4ALDH1A1POLBCA12CA1
SCHEMBL4605917 0.72 KDM1A (0.77) KDM1AMAOAMAOBKCNH2
SCHEMBL4608402 0.69 ALDH1A1 (0.38) KDM1AMAOAMAOBALDH1A1KCNH2
SCHEMBL4606323 0.68 GRIA4 (0.70) GRIA4KDM1AKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1246797-B1 CYCLOPENTYL SULFONAMIDE DERIVATIVES LILLY CO ELI (US) 2008-07-23 EP claimed
US-6639107-B1 Potentiating glutamate receptor function ELI LILLY AND COMPANY 2003-10-28 US claimed
EP-1246797-A1 CYCLOPENTYL SULFONAMIDE DERIVATIVES ELI LILLY AND COMPANY (US) 2002-10-09 EP claimed
WO-2001042203-A1 CYCLOPENTYL SULFONAMIDE DERIVATIVES ELI LILLY AND COMPANY (US) 2001-06-14 WO claimed
EP-1246797-B1 CYCLOPENTYL SULFONAMIDE DERIVATIVES LILLY CO ELI (US) 2008-07-23 EP disclosed
US-6639107-B1 Potentiating glutamate receptor function ELI LILLY AND COMPANY 2003-10-28 US disclosed
EP-1246797-A1 CYCLOPENTYL SULFONAMIDE DERIVATIVES ELI LILLY AND COMPANY (US) 2002-10-09 EP disclosed
WO-2001042203-A1 CYCLOPENTYL SULFONAMIDE DERIVATIVES ELI LILLY AND COMPANY (US) 2001-06-14 WO disclosed